Maternal serum inhibin A can predict pre-eclampsia
Article first published online: 19 AUG 2005
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 105, Issue 10, pages 1101–1103, October 1998
How to Cite
Cuckle, H., Sehmi, I. and Jones, R. (1998), Maternal serum inhibin A can predict pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology, 105: 1101–1103. doi: 10.1111/j.1471-0528.1998.tb09943.x
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 26 September 1997 Returned for revision 23 March 1998 Accepted 2 April 1998
Objective To compare median levels of maternal serum inhibin A in the second trimester blood samples of women who subsequently develop pre-eclampsia and those who do not.
Design Retrospective analysis of 13–18 week samples from a bank of serum stored at −40°C, originally taken for Down's syndrome screening.
Setting Antenatal clinics in a teaching hospital.
Sample Twenty-eight pregnancies with pre-eclampsia and 701 controls. Samples were taken, on average, 22 weeks before the diagnosis.
Main outcome measure Median inhibin A level.
Results The median inhibin A level in the cases was 2.01 multiples of the gestation-specific median in the controls, a statistically significant elevation (P < 0.001). Twenty-three (82%) had levels above the normal median; 19 (68%), 15 (54%), and 11 (39%) exceeded the normal 75th, 90th and 95th centiles, respectively.
Conclusions In pre-eclampsia the maternal serum inhibin A level can be increased months before the onset of symptoms. This provides an opportunity to study the early natural history of the disease and possibly to conduct treatment trials.